Association of a Novel Gene Polymorphism with Susceptibility to Schizophrenia and Breast Cancer: A Case-Control Study.

BACKGROUND

gene is found to play essential roles in regulating different aspects of cell proliferation and development of the nervous system. We aimed to determine if rs12407427 T/C polymorphism could affect susceptibility to schizophrenia (SZN) and breast cancer (BC), the two genetically correlated diseases.

METHODS

The current case-control study was performed from Aug 2018 to Dec 2018. Briefly, 159 female pathologically confirmed BC cases referring to Alzahra Hospital, Isfahan, Iran, and 102 psychologically confirmed SZN patients (60 males and 42 females) admitted to Baharan Hospital, Zahedan, Iran, were enrolled. Using the salting-out method, genomic DNA was extracted, and variants were genotyped using allele-specific amplification refractory mutation system polymerase chain reaction (ARMS-PCR) method.

RESULTS

The results revealed a significant association between the rs12407427 codominant CT (0.001), CC (0.0001), dominant CT+CC, and recessive CC (0.001) genotypes with the risk of developing SZN. Significant correlations were also found regarding rs12407427 and BC susceptibility in different inheritance models, including over-dominant CT (0.026), dominant CT+CC (0.001), recessive CC (0.009), and codominant CT and CC (0.001) genotypes. The over-presence of the C allele was also correlated with an increased risk for SZN (0.0001) and BC (0.0001). Finally, computational analysis predicted that T/C variation in this polymorphism could change the binding sites in proteins involved in splicing.

CONCLUSION

rs12407427 T/C as a de novo variant might be a novel genetic biomarker for SZN and/or BC susceptibility in a sample of the Iranian population.